Skip to content
  • 6,751 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Justification

Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation

BARDA-IEIDD-063025

Office of Assistant Secretary for Preparedness and Response, Aspr Barda Div Contracts MGMT & Acq. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

130 open like this View on SAM.gov Markdown

Awarded

PPD Development LP

$0.00 obligated so far on USAspending, September 29, 2023, contract 75A50123C00045

Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities

This one was awarded in 2025

130 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

All 130 open in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

Description

As published on SAM.gov.

This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are:

1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s).

2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
PPD Development LP
UEI
ZANENSW6C665
CAGE
3FAW2
Vendor location
Wilmington, NC
Contract
75A50123C00045, definitive contract
Obligated
$0.00, current value $126,485,055
Actions
6 between February 29, 2024 and August 18, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Advanced Research and Development Activities for Novel Immunogenicity Assays and Sample Collection Technologies as Part of Barda?s Continuing Support for Covid-19 Vaccine Development, Assessing Impact of Variants on Vaccine Immunogenicity, and Analyz
Match
award number 75A50123C00045 equals the contract number; same sub-agency 7505 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. June 30, 2025

    Justification

    SAM.gov, notice f4eb98d18fa441c0b1883cda9980e36f

Points of contact